Qiagen (NYSE:QGEN) Issues FY 2025 Earnings Guidance

Key Points

• Qiagen has issued its FY 2025 earnings guidance with an EPS of $2.350, slightly above the consensus estimate of $2.348, along with revenue guidance of $2.1 billion.
• The company recently declared a dividend of $0.25 per share, with a dividend yield of 52.0% and a payout ratio of 62.50%.
• Analysts generally have a mixed outlook on Qiagen, with price targets ranging from $43.00 to $55.00 and a consensus rating of Hold.

Qiagen (NYSE:QGEN - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 2.350-2.350 for the period, compared to the consensus EPS estimate of 2.348. The company issued revenue guidance of $2.1 billion-$2.1 billion, compared to the consensus revenue estimate of $2.1 billion. Qiagen also updated its Q3 2025 guidance to 0.580- EPS.

Qiagen Trading Down 0.7%

QGEN traded down $0.34 during midday trading on Tuesday, hitting $49.91. The company's stock had a trading volume of 2,073,954 shares, compared to its average volume of 1,377,790. The company has a current ratio of 3.37, a quick ratio of 2.83 and a debt-to-equity ratio of 0.40. Qiagen has a 52-week low of $37.63 and a 52-week high of $51.88. The firm has a market cap of $11.09 billion, a P/E ratio of 125.14, a PEG ratio of 2.54 and a beta of 0.64. The firm has a 50-day moving average price of $47.71 and a two-hundred day moving average price of $43.46.

Qiagen (NYSE:QGEN - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.60 earnings per share for the quarter, hitting analysts' consensus estimates of $0.60. Qiagen had a return on equity of 14.61% and a net margin of 4.68%. On average, research analysts anticipate that Qiagen will post 2.26 earnings per share for the current year.

Qiagen Dividend Announcement

The firm also recently declared a dividend, which was paid on Thursday, July 10th. Stockholders of record on Thursday, July 3rd were issued a dividend of $0.25 per share. This represents a dividend yield of 52.0%. The ex-dividend date of this dividend was Wednesday, July 2nd. Qiagen's dividend payout ratio (DPR) is 62.50%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on QGEN shares. Bank of America raised their price target on Qiagen from $50.00 to $53.00 and gave the company a "buy" rating in a report on Thursday, June 26th. Robert W. Baird raised their price target on Qiagen from $42.00 to $43.00 and gave the company a "neutral" rating in a report on Monday, April 21st. Barclays started coverage on Qiagen in a research note on Tuesday, June 24th. They set an "overweight" rating and a $55.00 target price for the company. Finally, Wall Street Zen raised Qiagen from a "buy" rating to a "strong-buy" rating in a research note on Sunday. Seven equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Qiagen currently has a consensus rating of "Hold" and a consensus price target of $49.40.

Hedge Funds Weigh In On Qiagen

An institutional investor recently bought a new position in Qiagen stock. United Services Automobile Association bought a new position in Qiagen N.V. (NYSE:QGEN - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 5,946 shares of the company's stock, valued at approximately $239,000. Institutional investors own 70.00% of the company's stock.

Qiagen Company Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.